Tag: Rex Medical
VIVA 2019: Revolution system meets primary and safety endpoints in REVEAL...
Findings from the REVEAL study confirm a favourable safety and effectiveness profile through six months for the Revolution peripheral atherectomy system from Rex Medical....
Rex Medical receives 510k clearance for Revolution Peripheral Atherectomy System
Rex Medical recently announced that it has received 510k clearance from the US Food and Drug Administration (FDA) for the Revolution Peripheral Atherectomy System.
Regulatory...
